Genzyme Corp launches a tender offer for AnorMED Inc

CANADA - Genzyme Corp (GC) acquired all the outstanding common stock of AnorMED Inc (AM), a biopharmaceutical company, for a sweetened ##.# Canadian dollars ($##.## US) in cash per share, or a total value of C$###.### mil…

Deal Information

Credit & Investment Research

Market Research

News

Genzyme Corp Mergers & Acquisitions

Genzyme Corp acquires Targeted Genetics Corp-Mnfg As from Targeted Genetics Corp (9/9/2009 12:00:00 AM)

Genzyme Corp acquires Bayer Healthcare-Portfolio from Bayer AG (6/2/2009 12:00:00 AM)

Genzyme Corp acquires a minority stake in EXACT Sciences Corp (1/27/2009 12:00:00 AM)

Genzyme Corp acquires EXACT Sciences Corp-Certain from EXACT Sciences Corp (1/27/2009 12:00:00 AM)

Genzyme Corp acquires Diagnostic Chem Ltd-Diagnostic from Diamant Co Ltd (pending) (11/9/2007 12:00:00 AM)

Genzyme Corp acquires Bioenvision Inc (7/10/2007 12:00:00 AM)

Genzyme Corp intends a stock buyback (5/29/2007 12:00:00 AM)

Genzyme Corp acquires Brennen Medical Inc-GlucaTex from Brennen Medical Inc (4/12/2006 12:00:00 AM)

Genzyme Corp acquires Avigen Inc-Gene Therapy Assets from Avigen Inc (12/21/2005 12:00:00 AM)

Genzyme Corp acquires Cell Genesys Inf-Mnfg Op from Cell Genesys Inc (11/22/2005 12:00:00 AM)

AnorMED Inc Mergers & Acquisitions

Millennium Pharmaceuticals Inc withdraws offer for AnorMED Inc (9/26/2006 12:00:00 AM)

Shire Pharmaceuticals Grp PLC acquires AnorMED-Fosrenol Global Patent from AnorMED Inc (3/23/2004 12:00:00 AM)

Johnson Matthey PLC acquires a minority stake in AnorMED Inc (pending) (7/1/1996 12:00:00 AM)